Immune-Checkpoint Blockade Therapy in Lymphoma

Tumor cells use immune-checkpoint pathways to evade the host immune system and suppress immune cell function. These cells express programmed cell-death protein 1 ligand 1 (PD-L1)/PD-L2, which bind to the programmed cell-death protein 1 (PD-1) present on cytotoxic T cells, trigger inhibitory signalin...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuzume, Ayumi, Chi, SungGi, Yamauchi, Nobuhiko, Minami, Yosuke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7432396/
https://www.ncbi.nlm.nih.gov/pubmed/32751706
http://dx.doi.org/10.3390/ijms21155456

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7432396/
https://www.ncbi.nlm.nih.gov/pubmed/32751706
http://dx.doi.org/10.3390/ijms21155456

Ejemplares similares